Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC50 Values against MDR S. epidermidis

Molecular Pharmaceutics
Jitendra WankarIlse Manet

Abstract

Clofazimine (CLZ) is an antibiotic with a promising behavior against Gram-positive bacteria; however, the drug is completely insoluble in water and accumulates in fat tissues. We explored nanocarriers, labeled and not labeled with rhodamine, consisting of negatively charged sulfobutylether-β-cyclodextrins for CLZ loading. A new oligomeric carrier was obtained cross-linking βCyD with epichlorohydrin followed by sulfonation in a strongly alkaline aqueous medium. The oligomeric carrier has a MW of 53 kDa and forms small nanoparticles of a few tens of nm. With aqueous solutions containing a 25 mg/mL oligomeric carrier, we loaded up to 0.5 mg/mL of drug. The oligomers exhibited a 10-fold better loading capacity compared to monomers and formed nanoparticles with a size in the 20-60 nm range after drug loading. Circular dichroism confirmed encapsulation of the CLZ in the nanocarriers. All carriers with or without CLZ are not cytotoxic up to 1 μM, while CLZ alone is highly cytotoxic at the same concentration. The drug has IC50 values below 100 nM against S. epidermidis. The same holds true also for clinical isolates of S. epidermidis, some displaying MDR. So, the selectivity index significantly increased for CLZ/carrier systems compare...Continue Reading

References

Jun 1, 1979·Leprosy Review·S J Yawalkar, W Vischer
Dec 1, 1992·Antimicrobial Agents and Chemotherapy·C E Van RensburgR Anderson
Feb 1, 1989·Clinical Pharmacokinetics·M R Holdiness
Jan 1, 1995·Drug Metabolism Reviews·R O'ConnorR O'Kennedy
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·V M ReddyP R Gangadharam
Jun 24, 2003·International Journal of Pharmaceutics·Isam Ismail SalemNejat Düzgünes
Dec 2, 2004·Nature Reviews. Drug Discovery·Mark E Davis, Marcus E Brewster
May 20, 2008·Tuberculosis
Aug 27, 2009·Expert Opinion on Drug Delivery·Erem Bilensoy, A Atilla Hincal
Oct 25, 2011·The Journal of Antimicrobial Chemotherapy·Moloko C CholoRonald Anderson
May 12, 2012·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Resmi AnandSandra Monti
Nov 28, 2012·Antimicrobial Agents and Chemotherapy·Rahul Kumar VermaAmit Misra
Apr 11, 2013·Chemical Communications : Chem Comm·Aurore FraixSalvatore Sortino
Jul 31, 2013·Advanced Drug Delivery Reviews·Robert Y Pelgrift, Adam J Friedman
Sep 10, 2013·Journal of Pharmaceutical and Biomedical Analysis·Andrea ZattoniPierluigi Reschiglian
Oct 4, 2014·Clinical Microbiology Reviews·Karsten BeckerGeorg Peters
Jan 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hinojal ZazoJosé M Lanao
May 7, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Sabrina ValettiIlse Manet

❮ Previous
Next ❯

Citations

Jun 20, 2019·International Journal of Molecular Sciences·Lorenzo AngioliniAbderrazzak Douhal
Feb 2, 2021·Drug Delivery and Translational Research·Federico QuattriniMaría José Alonso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.